Literature DB >> 24552816

Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.

Wensheng Yang1, Mariana Cooke1, Colin S Duckett2, Xiaolu Yang3, Jay F Dorsey1.   

Abstract

Inhibitor of apoptosis proteins (IAPs) are extensively involved in NFκB signaling pathways. Regulation of c-IAP2 turnover by other proteins was investigated in glioblastoma multiforme (GBM) cells in the present study. When overexpressed, X-linked IAP (XIAP) enhanced expression of ectopic c-IAP2, but not c-IAP1, and endogenous c-IAP2 levels were reduced once XIAP expression was silenced. TNFα stimulation substantially increased c-IAP2 expression, and this upregulation was impaired by suppression of XIAP. Similarly, when XIAP was limiting due to severe hypoxic conditions, c-IAP2 levels were downregulated. These data together indicate that XIAP is an important regulator responsible for stabilization of c-IAP2 levels under different conditions. Protein interactions occur through binding of BIR2 and BIR3 domains of c-IAP2 with the RING finger of XIAP. XIAP inhibition of c-IAP2 auto-degradation was dependent on this physical interaction, and it was independent of XIAP E3 ligase activity. Global c-IAP2 ubiquitination was not affected by XIAP, although c-IAP2 levels were significantly increased. A CARD-RING-containing fragment of c-IAP2 was found to target XIAP for proteasome-independent degradation, but it was unable to sensitize GBM cells to chemo-reagents. The XIAP-stabilized c-IAP2 was found to enhance IκB-α phosphorylation on serines 32 and 36, and to antagonize XIAP-induced increase in mature Smac and Bcl10. Taken together, our data identify a distinctive role of c-IAP2 as stabilizer of XIAP, which is likely involved in regulation of NFκB activation and apoptosis in GBM cells.

Entities:  

Keywords:  Bcl10; IκB-α; TNFα; XIAP; anoxia; auto-degradation; c-IAP2; glioblastoma multiforme cell lines; mature Smac

Mesh:

Substances:

Year:  2014        PMID: 24552816      PMCID: PMC3984322          DOI: 10.4161/cc.27880

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  50 in total

1.  Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli.

Authors:  Y Yang; S Fang; J P Jensen; A M Weissman; J D Ashwell
Journal:  Science       Date:  2000-05-05       Impact factor: 47.728

Review 2.  The hallmarks of cancer.

Authors:  D Hanahan; R A Weinberg
Journal:  Cell       Date:  2000-01-07       Impact factor: 41.582

3.  Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia. Hif-1-independent mechanisms.

Authors:  Z Dong; M A Venkatachalam; J Wang; Y Patel; P Saikumar; G L Semenza; T Force; J Nishiyama
Journal:  J Biol Chem       Date:  2001-03-12       Impact factor: 5.157

4.  TNF-RII and c-IAP1 mediate ubiquitination and degradation of TRAF2.

Authors:  Xiaoming Li; Yili Yang; Jonathan D Ashwell
Journal:  Nature       Date:  2002-03-21       Impact factor: 49.962

5.  c-IAP1 is cleaved by caspases to produce a proapoptotic C-terminal fragment.

Authors:  R J Clem; T T Sheu; B W Richter; W W He; N A Thornberry; C S Duckett; J M Hardwick
Journal:  J Biol Chem       Date:  2000-12-05       Impact factor: 5.157

6.  Characterization of XIAP-deficient mice.

Authors:  H Harlin; S B Reffey; C S Duckett; T Lindsten; C B Thompson
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

7.  Cellular inhibitors of apoptosis proteins cIAP1 and cIAP2 are required for efficient caspase-1 activation by the inflammasome.

Authors:  Katherine Labbé; Christian R McIntire; Karine Doiron; Philippe M Leblanc; Maya Saleh
Journal:  Immunity       Date:  2011-12-23       Impact factor: 31.745

8.  Dissecting the complex regulation of Mad4 in glioblastoma multiforme cells.

Authors:  Wensheng Yang; Xiaolu Yang; Gregory David; Jay F Dorsey
Journal:  Cancer Biol Ther       Date:  2012-08-16       Impact factor: 4.742

9.  Smac mimetic sensitizes glioblastoma cells to Temozolomide-induced apoptosis in a RIP1- and NF-κB-dependent manner.

Authors:  L Wagner; V Marschall; S Karl; S Cristofanon; K Zobel; K Deshayes; D Vucic; K-M Debatin; S Fulda
Journal:  Oncogene       Date:  2012-04-02       Impact factor: 9.867

10.  E3 ligase activity of XIAP RING domain is required for XIAP-mediated cancer cell migration, but not for its RhoGDI binding activity.

Authors:  Jinyi Liu; Dongyun Zhang; Wenjing Luo; Jianxiu Yu; Jingxia Li; Yonghui Yu; Xinhai Zhang; Jingyuan Chen; Xue-Ru Wu; Chuanshu Huang
Journal:  PLoS One       Date:  2012-04-19       Impact factor: 3.240

View more
  14 in total

Review 1.  Screening for E3-ubiquitin ligase inhibitors: challenges and opportunities.

Authors:  Vivien Landré; Barak Rotblat; Sonia Melino; Francesca Bernassola; Gerry Melino
Journal:  Oncotarget       Date:  2014-09-30

2.  The 1,4 benzoquinone-featured 5-lipoxygenase inhibitor RF-Id induces apoptotic death through downregulation of IAPs in human glioblastoma cells.

Authors:  S Zappavigna; M Scuotto; A M Cossu; D Ingrosso; M De Rosa; C Schiraldi; R Filosa; M Caraglia
Journal:  J Exp Clin Cancer Res       Date:  2016-10-22

Review 3.  Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications.

Authors:  Silvia Anahi Valdés-Rives; Diana Casique-Aguirre; Liliana Germán-Castelán; Marco A Velasco-Velázquez; Aliesha González-Arenas
Journal:  Biomed Res Int       Date:  2017-11-12       Impact factor: 3.411

4.  A small-molecule ARTS mimetic promotes apoptosis through degradation of both XIAP and Bcl-2.

Authors:  Dana Mamriev; Ruqaia Abbas; Franca-Maria Klingler; Juliana Kagan; Nir Kfir; Alastair Donald; Keren Weidenfeld; David W Sheppard; Dalit Barkan; Sarit Larisch
Journal:  Cell Death Dis       Date:  2020-06-25       Impact factor: 8.469

5.  Sustained NF-κB-STAT3 signaling promotes resistance to Smac mimetics in Glioma stem-like cells but creates a vulnerability to EZH2 inhibition.

Authors:  Bakhos A Tannous; Christian E Badr; Cintia Carla da Hora; Kelsey Pinkham; Litia Carvalho; Max Zinter; Elie Tabet; Ichiro Nakano
Journal:  Cell Death Discov       Date:  2019-03-04

6.  X-linked inhibitor of apoptosis protein (XIAP) lacking RING domain localizes to the nuclear and promotes cancer cell anchorage-independent growth by targeting the E2F1/Cyclin E axis.

Authors:  Zipeng Cao; Xueyong Li; Jingxia Li; Wenjing Luo; Chuanshu Huang; Jingyuan Chen
Journal:  Oncotarget       Date:  2014-08-30

7.  BIRC3 is a novel driver of therapeutic resistance in Glioblastoma.

Authors:  Dapeng Wang; Anders Berglund; Rajappa S Kenchappa; Peter A Forsyth; James J Mulé; Arnold B Etame
Journal:  Sci Rep       Date:  2016-02-18       Impact factor: 4.379

8.  Analysis of the inhibitors of apoptosis identifies BIRC3 as a facilitator of malignant progression in glioma.

Authors:  Loyola V Gressot; Tiffany Doucette; Yuhui Yang; Gregory N Fuller; Ganiraju Manyam; Arvind Rao; Khatri Latha; Ganesh Rao
Journal:  Oncotarget       Date:  2017-02-21

9.  Transcriptome sequencing of neurologic diseases associated genes in HHV-6A infected human astrocyte.

Authors:  Qing Shao; Zhe Lin; Xiaohui Wu; Junwei Tang; Shuai Lu; Dongju Feng; Ci Cheng; Lanqun Qing; Kun Yao; Yun Chen
Journal:  Oncotarget       Date:  2016-07-26

Review 10.  Drug Repositioning in Glioblastoma: A Pathway Perspective.

Authors:  Sze Kiat Tan; Anna Jermakowicz; Adnan K Mookhtiar; Charles B Nemeroff; Stephan C Schürer; Nagi G Ayad
Journal:  Front Pharmacol       Date:  2018-03-16       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.